pergolide has been researched along with Cirrhosis in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (6.25) | 18.2507 |
2000's | 15 (93.75) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andersohn, F; Garbe, E | 1 |
Berendse, H; Bloem, BR; Boon, AJ; de Koning-Tijssen, MA; Hovestadt, A; Nijssen, PC; van Hilten, JJ; van Laar, T; Weber, WE | 1 |
Caveliers, V; Cosyns, B; Degaillier, C; Droogmans, S; Franken, PR; Garbar, C; Hernot, S; Lahoutte, T; Pipeleers-Marichal, M; Roosens, B; Schoors, D; Van Camp, G; Weytjens, C | 1 |
Bhattacharyya, S; Davar, J; Mikhailidis, DP; Schapira, AH | 1 |
Lanier, WL | 1 |
Bagheri, H; Montastruc, JL; Pathak, A | 1 |
Agarwal, P; Fahn, S; Frucht, SJ | 1 |
Horowski, R; Jähnichen, S; Pertz, HH | 1 |
Basu, S; Chaudhuri, KR; Dhawan, V; Jackson, G; Odin, P | 1 |
Bagheri, H; Montastruc, JL; Pathak, A; Rascol, O | 1 |
Roth, J; Růzicka, E; Ulmanová, O | 1 |
Fuhrmann, JT; Junghanns, S; Koch, R; Oelwein, C; Reichmann, H; Simonis, G; Storch, A; Strasser, RH | 1 |
Grandas, F | 1 |
Chihara, N; Hayakawa, M; Nakase, H; Shiio, Y; Yoshimura, M | 1 |
Dick, DJ; Pilling, JB; Shaunak, S; Wilkins, A | 1 |
Danoff, SK; Flynn, JA; Grasso, ME; Terry, PB | 1 |
2 review(s) available for pergolide and Cirrhosis
Article | Year |
---|---|
Drug-induced fibrotic valvular heart disease.
Topics: Antiparkinson Agents; Appetite Depressants; Cabergoline; Dexfenfluramine; Dopamine Agonists; Drug Monitoring; Ergolines; Ergotamine; Fenfluramine; Fibrosis; Heart Valve Diseases; Heart Valves; Humans; Methysergide; Migraine Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Patient Selection; Pergolide; Receptors, Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Vasoconstrictor Agents | 2009 |
[Cardiac valvulopathy and dopamine agonist].
Topics: Antiparkinson Agents; Biomedical Research; Dopamine Agonists; Fibrosis; Heart Valve Diseases; Heart Valves; Humans; Pergolide | 2007 |
1 trial(s) available for pergolide and Cirrhosis
Article | Year |
---|---|
Valvular heart disease in Parkinson's disease patients treated with dopamine agonists: a reader-blinded monocenter echocardiography study.
Topics: Benzothiazoles; Cabergoline; Dopamine Agonists; Double-Blind Method; Echocardiography; Ergolines; Female; Fibrosis; Heart Valve Diseases; Humans; Hypertrophy, Left Ventricular; Indoles; Male; Middle Aged; Mitral Valve Insufficiency; Parkinson Disease; Pergolide; Pramipexole; Severity of Illness Index; Tricuspid Valve Insufficiency | 2007 |
13 other study(ies) available for pergolide and Cirrhosis
Article | Year |
---|---|
Cardiac and noncardiac fibrotic reactions caused by ergot-and nonergot-derived dopamine agonists.
Topics: Aged; Aged, 80 and over; Apomorphine; Benzothiazoles; Bromocriptine; Cabergoline; Databases, Factual; Dopamine Agonists; Endomyocardial Fibrosis; Ergolines; Female; Fibrosis; Heart Valve Diseases; Humans; Indoles; Male; Middle Aged; Pergolide; Pericarditis; Pleural Diseases; Pramipexole; Pulmonary Fibrosis; Retroperitoneal Fibrosis; Tetrahydronaphthalenes; Thiophenes; United States | 2009 |
[Pergolide use and heart valve fibrosis. Yearly control in patients with Parkinson disease who use pergolide].
Topics: Dopamine Agonists; Echocardiography; Fibrosis; Heart Valve Diseases; Humans; Parkinson Disease; Pergolide; Risk Factors | 2009 |
Cyproheptadine prevents pergolide-induced valvulopathy in rats: an echocardiographic and histopathological study.
Topics: Animals; Blood Pressure; Body Weight; Cyproheptadine; Dopamine Agonists; Drug Interactions; Echocardiography; Fibrosis; Heart Valve Diseases; Heart Valves; Male; Myocytes, Cardiac; Pergolide; Rats; Rats, Wistar; Serotonin Antagonists | 2009 |
Additional insights into pergolide-associated valvular heart disease.
Topics: Adverse Drug Reaction Reporting Systems; Dopamine Agonists; Evidence-Based Medicine; Fibrosis; Heart Valve Diseases; Humans; Incidence; Pergolide; Registries; Serotonin | 2003 |
[Pergolide treatment and cardiac valve pathology: the continuing saga of ergotamine-induced fibrosis].
Topics: Dopamine Agonists; Ergotamine; Fibrosis; Heart Diseases; Heart Valve Diseases; Humans; Pergolide; Vasoconstrictor Agents | 2004 |
Diagnosis and management of pergolide-induced fibrosis.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Biopsy, Needle; Bronchi; Female; Fibrosis; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Pergolide; Pleural Diseases; Retroperitoneal Fibrosis; Tomography, X-Ray Computed | 2004 |
Fibrotic valvular heart disease is not related to chemical class but to biological function: 5-HT2B receptor activation plays crucial role.
Topics: Dopamine Agents; Fibroblasts; Fibrosis; Heart Valve Diseases; Humans; Myoblasts; Parkinson Disease; Pergolide; Receptors, Serotonin | 2004 |
Valvular heart disease and fibrotic reactions may be related to ergot dopamine agonists, but non-ergot agonists may also not be spared.
Topics: Aortic Valve; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Fibrosis; Heart Valve Diseases; Humans; Parkinson Disease; Pergolide | 2004 |
Dopaminagonists and fibrotic valvular heart disease: further considerations.
Topics: Dopamine Agonists; Fibrosis; Heart Valve Diseases; Humans; Parkinson Disease; Pergolide | 2004 |
[Organ changes induced by ergot derivative dopamine agonist drugs: time to change treatment guidelines in Parkinson's disease?].
Topics: Aged; Dopamine Agonists; Female; Fibrosis; Humans; Male; Middle Aged; Parkinson Disease; Pergolide | 2005 |
[Low dose pergolide induced systemic edema and pleural effusion in a patient with Parkinson's disease].
Topics: Aged; Edema; Female; Fibrosis; Heart Valves; Humans; Parkinson Disease; Pergolide; Peritoneum; Pleura; Pleural Effusion; Severity of Illness Index | 2008 |
Pericardial, retroperitoneal, and pleural fibrosis induced by pergolide.
Topics: Aged; Antiparkinson Agents; Fibrosis; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Pericardium; Pleura; Retroperitoneal Fibrosis | 1999 |
Pleuropulmonary disease due to pergolide use for restless legs syndrome.
Topics: Aged; Dopamine Agonists; Fibrosis; Humans; Male; Pergolide; Pleural Diseases; Pleural Effusion; Pulmonary Fibrosis; Restless Legs Syndrome | 2001 |